IMA901 for metastatic renal cell carcinoma in the context of new approaches to immunotherapy.
about
Immunobiology and immunotherapy in genitourinary malignanciesPeptide-Based Treatment: A Promising Cancer TherapyNew clinical advances in immunotherapy for the treatment of solid tumours.Personalized immunotherapy ( AGS-003 ) when combined with sunitinib for the treatment of metastatic renal cell carcinoma.Immunotherapeutic strategies for the treatment of renal cell carcinoma: Where will we go?Differential expression and clinical relevance of MUC1 in renal cell carcinoma metastasis.
P2860
IMA901 for metastatic renal cell carcinoma in the context of new approaches to immunotherapy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
IMA901 for metastatic renal ce ...... w approaches to immunotherapy.
@en
type
label
IMA901 for metastatic renal ce ...... w approaches to immunotherapy.
@en
prefLabel
IMA901 for metastatic renal ce ...... w approaches to immunotherapy.
@en
P2860
P356
P1433
P1476
IMA901 for metastatic renal ce ...... ew approaches to immunotherapy
@en
P2093
Arnulf Stenzl
Steffen Rausch
P2860
P304
P356
10.2217/FON.14.61
P407
P577
2014-05-01T00:00:00Z